The 5th International mRNA Health Conference to Showcase Advances in mRNA Cancer Therapy, Antibody Development and Vaccines
- Early-Bird Registration Closes September 15, 2017
- Conference Scheduled for November 1-2, 2017 / Berlin, Germany
TÜBINGEN, Germany and BERLIN, Sept. 12, 2017 /PRNewswire/ -- The 5th International mRNA Health Conference has unveiled the preliminary schedule for its two-day conference taking place on November 1-2 in Berlin, Germany. The conference will include talks and panel discussions focused on the evolution of groundbreaking mRNA research to next-generation pharmaceutical products targeting treatment opportunities in cancer, vaccination against infectious diseases, as well as antibody development and protein replacement therapy. The event will be highlighted by a keynote address from extreme mountaineer Reinhold Messner.
Early-bird registration for the 5th International mRNA Health Conference ends on September 15, 2017. To register and benefit from the discounted entry fee, please visit http://mrna-conference.com/register/.
The 5th International mRNA Health Conference
| Date: |
November 1-2, 2017 |
| Place: |
Berlin, Germany |
| Location: |
Sofitel Berlin Kurfürstendamm, Augsburger Strasse 41, 10789 Berlin, Germany |
| Website: |
|
| Program: |
The Conference, organized by BioNTech, CureVac and Moderna, will provide a comprehensive program around the medical use of Messenger RNA. Hundreds of world renowned innovators, scientists, academia and pharmaceutical delegates are expected to attend the conference as mRNA therapeutic technology evolves from scientific concept to medical application. Approximately 25 speakers will present on preclinical and clinical development in the fields of oncology, infectious diseases and molecular therapies as well as mRNA delivery, design and product development. Additionally, a poster session will provide research groups and company representatives the opportunity to showcase their data to attendees. |
| Registration: |
Register by September 15th and benefit from early bird prices |
| Contact: |
Media Contacts
Verena Lauterbach, Senior Manager Communications
CureVac AG, Tübingen, Germany
T: +49 (0) 7071 9883 1756
[email protected]
Jason Rando, EVP & COO
Tiberend Strategic Advisors, New York
+1 212 375 2665
[email protected]
SOURCE CureVac
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article